Lyvispah
Product Images NDC 70257-412

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lyvispah (NDC 70257-412). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Saol Therapeutics Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Lyvispah 01)

Chemical structure of the active ingredient shown on the Lyvispah product labeling. The structure includes a benzene ring with a chlorine substituent and two side chains containing CH2CO2H and CH2NH2 groups.*

FDA Label Image

Packet-image (Lyvispah 02)

Lyvispah (baclofen) oral granules packaging label panel showing usage instructions to cut the package open with scissors. The label includes the proprietary name Lyvispah with the active ingredient baclofen indicated below it. The label is in black and white with dashed lines above the scissors icon.*

FDA Label Image

5mg Carton (Lyvispah 03)

Packaging label for Lyvispah 5 mg (baclofen) oral granules by Saol Therapeutics Inc. The carton contains 90 individual packets for oral administration. Directions for use, dosage information, caution statements, storage conditions, and a barcode are shown on the label.*

FDA Label Image

5mg Container (Lyvispah 04)

Lyvispah 5 mg (baclofen) oral granules packaging label distributed by Saol Therapeutics, Inc. The label indicates child-resistant packaging and provides storage instructions to keep the product at 20°C to 25°C (68°F to 77°F) with allowed excursions between 15°C and 30°C (59°F to 86°F). The label includes Rx Only designation and space for lot and expiration date.*

FDA Label Image

10mg Carton (Lyvispah 05)

Packaging label for Lyvispah 10 mg (baclofen) oral granules by Saol Therapeutics Inc. The carton contains 90 individual packets for oral administration with recommended dosage information and directions for use. The label includes storage instructions, barcode, and tamper-evident warnings.*

FDA Label Image

10mg Container (Lyvispah 06)

Label for Lyvispah 10 mg baclofen oral granules. The label states the product is distributed by Saol Therapeutics, Inc. It includes storage instructions at 20°C to 25°C with permissible excursions. The package is child-resistant, and each packet contains 10 mg baclofen. Lot and expiration date fields are present but not filled.*

FDA Label Image

20mg Carton (Lyvispah 07)

Lyvispah 20 mg oral granules packaging label by Saol Therapeutics Inc. The label displays the product name, active ingredient baclofen 20 mg per packet, and instructions for use. It notes the package contains 90 individual packets and includes storage information, caution statements, and a barcode with the Saol Therapeutics logo. The design features orange and lavender colors with Rx Only and NDC 70257-416-87.*

FDA Label Image

20mg Container (Lyvispah 08)

Label for Lyvispah 20 mg oral granules containing baclofen, distributed by Saol Therapeutics Inc. The label includes storage instructions for temperature control and states the package is child-resistant. It also notes that each packet contains 20 mg baclofen and is Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.